Publication date: Jul 08, 2026
Melanoma outcomes vary by subgroups. Identify institutional/systemic factors contributing to outcome differences. Retrospective cohort study of melanoma patients seen 1/1987-5/2023 at a VA center and nearby tertiary care center sharing providers. Outcomes include melanoma-specific survival (MSS) and mortality (MSM). Compared to the tertiary center (n=9,682, 5,564 males), VA patients (n=638, 612 males) were older and had a greater proportion of melanoma in situ (p
| Concepts | Keywords |
|---|---|
| Mortality | clinical research |
| Nearby | melanoma |
| Physician | melanoma mortality |
| melanoma-specific survival | |
| oncology | |
| tertiary care center | |
| veterans affairs |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | melanoma |
| pathway | KEGG | Melanoma |
| disease | MESH | MSS |
| drug | DRUGBANK | Dimethyl sulfone |
Original Article
(Visited 42 times, 1 visits today)